|
|
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192990-04
|
$165,747
|
$99,448
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-08
|
$704,474
|
$112,716
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
|
5R01CA185457-04
|
$640,378
|
$640,378
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
|
(PQC4) Habitats in Prostate Cancer
|
5R01CA190105-04
|
$681,586
|
$681,586
|
GILLIES, ROBERT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
(PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc
|
5R01CA185509-04
|
$258,128
|
$258,128
|
GHOSH, PARAMITA
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$263,827
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
|
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
5P20CA202924-02
|
$229,982
|
$80,494
|
WILLIAMS, KEVIN
|
NORTH CAROLINA CENTRAL UNIVERSITY
|
|
|
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192973-04
|
$191,836
|
$95,918
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
1P20CA221697-01
|
$324,559
|
$3,246
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
|
2/2 Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192992-04
|
$158,966
|
$111,276
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
5P20CA202925-02
|
$255,626
|
$194,276
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-08
|
$919,471
|
$18,389
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-04
|
$144,556
|
$67,941
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
|
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
1P20CA221696-01
|
$221,442
|
$44,288
|
MCNEILL, LORNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-12
|
$407,680
|
$179,379
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118948-12
|
$1,170,535
|
$105,348
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
3D Prostate Histochemometry to Predict Disease Recurrence
|
5R01CA197516-02
|
$400,626
|
$400,626
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
|
402 -- A PHASE I TRIAL OF THE SAFETY IMMUNOGENICITY OF RG1-VLP... (PROTOCOL UWI2016-08-02). CONTRACTOR: UNIVERSITY OF WISCONSIN. CONTRACT NO: HHSN261201200033I, TASK ORDER: HHSN261000012. FROM 9/1
|
261201200033I
|
$1,485,915
|
$490,352
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
402 -- CHEMOPREVENTION OF COLORECTAL CANCER . CONTRACTOR: UNIVERSITY OF OKLAHOMA, HEALTH SCIENCES CENTER, DUNS: 878648294. CONTRACT NO: HHSN261500038I, TASK ORDER HHSN26100011. FROM 9/15/17 TO 9/14/
|
261201500038I
|
$1,236,052
|
$1,236,052
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
|
A blood test to identify prostate cancer patients at risk for visceral metastasis
|
1R01CA218356-01
|
$620,500
|
$620,500
|
POSADAS, EDWIN
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
A highly specific NIRF/PET probe for the detection of cancer and metastases
|
1R43CA210854-01A1
|
$224,958
|
$112,479
|
Yang, Xinlin
|
IMOL RADIOPHARMACEUTICALS, LLC
|
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$151,467
|
$75,733
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
|
A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials
|
5R01CA200718-02
|
$599,514
|
$599,514
|
EGGLY, SUSAN
|
WAYNE STATE UNIVERSITY
|
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
5R01CA166894-05
|
$1
|
$1
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use
|
5R01CA207645-02
|
$558,907
|
$558,907
|
WEBER, WOLFGANG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
|
2R44CA183362-02A1
|
$822,075
|
$411,038
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
|
A novel strategy to identify prostate cancer biomarkers for patient management
|
5R01CA172603-05
|
$329,925
|
$329,925
|
HUANG, JIAOTI
|
DUKE UNIVERSITY
|
|
|
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR
|
5R01CA200551-02
|
$247,249
|
$247,249
|
PARK, SEAN
|
MAYO CLINIC ROCHESTER
|
|
|
A Small-Molecule Inhibitor of the Terminal Steps for Intracrine Androgen Synthesis in Advanced Prostate Cancer
|
5R21CA205108-02
|
$259,734
|
$259,734
|
MOHLER, JAMES
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
|
5R21CA198237-02
|
$88,993
|
$17,799
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
|
A Target-Directed Reagent Pipeline via Microfluidic mRNA Display
|
1R21CA204708-01A1
|
$227,675
|
$113,838
|
MALMSTADT, NOAH
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
$35,159
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
$2,500
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
$1,250
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
$156,205
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Academic-Industrial Partnership for Translation of PET/TRUS Guided Intervention
|
1R01CA204254-01A1
|
$376,753
|
$376,753
|
FEI, BAOWEI
|
EMORY UNIVERSITY
|
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$256,560
|
$51,312
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
|
Active surveillance and patient reported outcomes in a diverse population of prostate cancer patients
|
1R01CA211141-01A1
|
$664,142
|
$664,142
|
GOMEZ, SCARLETT
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Adaptive resistance to HIF1a inhibition in hypoxia
|
5R01CA207377-02
|
$352,147
|
$116,209
|
QIAN, ZHENG DAVID
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
Advanced statistical modeling and analytics for prostate cancer interventions
|
1R50CA221836-01
|
$202,176
|
$202,176
|
GULATI, ROMAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI
|
5R01CA160902-06
|
$220,860
|
$220,860
|
MAIER, STEPHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention
|
5K05CA175147-04
|
$88,959
|
$88,959
|
STANFORD, JANET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Agricultural Cohort Consortium
|
ZIA CP010119-10537
|
$50,451
|
$5,045
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
$125,309
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
$668,707
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alteration of the miR-let-7c:Lin28 ratio as a predictor of therapy resistance in Prostate Cancer
|
1R03CA198696-01A1
|
$76,750
|
$76,750
|
NADIMINTY, NAGALAKSHMI
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
|
|
An inevitable mechanism of resistance to androgen-directed therapy
|
5R01CA188609-04
|
$312,288
|
$312,288
|
DONG, YAN
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
An integrated approach to dissect the functional network of large non-coding RNA
|
5R00CA175290-05
|
$221,939
|
$221,939
|
CHEN, YIWEN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Analysis of Blood Borne Markers in Hormone Sensitive Metastatic Prostate Cancer
|
5R01CA208254-02
|
$481,793
|
$481,793
|
SWEENEY, CHRISTOPHER
|
DANA-FARBER CANCER INST
|
|
|
Analysis of drug response in organoids and mouse models
|
5R01CA196662-02
|
$597,601
|
$597,601
|
SHEN, MICHAEL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Total relevant funding to Prostate for this search: $233,034,406
|
